UBS Group’s XBiotech XBIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15K Sell
5,051
-33,262
-87% -$98.8K ﹤0.01% 7317
2025
Q1
$124K Sell
38,313
-8,218
-18% -$26.6K ﹤0.01% 5621
2024
Q4
$184K Buy
46,531
+32,106
+223% +$127K ﹤0.01% 5300
2024
Q3
$112K Buy
14,425
+3,807
+36% +$29.4K ﹤0.01% 5088
2024
Q2
$54.6K Buy
10,618
+3,274
+45% +$16.8K ﹤0.01% 5481
2024
Q1
$59.7K Sell
7,344
-2,105
-22% -$17.1K ﹤0.01% 5269
2023
Q4
$37.8K Buy
9,449
+4,172
+79% +$16.7K ﹤0.01% 5505
2023
Q3
$21.7K Sell
5,277
-813
-13% -$3.35K ﹤0.01% 5626
2023
Q2
$36.2K Buy
6,090
+1,057
+21% +$6.28K ﹤0.01% 5574
2023
Q1
$17.4K Sell
5,033
-864
-15% -$2.98K ﹤0.01% 6092
2022
Q4
$20.7K Buy
5,897
+614
+12% +$2.16K ﹤0.01% 6437
2022
Q3
$19K Sell
5,283
-2,780
-34% -$10K ﹤0.01% 6379
2022
Q2
$45K Sell
8,063
-388
-5% -$2.17K ﹤0.01% 4992
2022
Q1
$73K Sell
8,451
-3,133
-27% -$27.1K ﹤0.01% 5129
2021
Q4
$129K Buy
11,584
+5,884
+103% +$65.5K ﹤0.01% 5008
2021
Q3
$74K Buy
5,700
+2,039
+56% +$26.5K ﹤0.01% 4963
2021
Q2
$61K Sell
3,661
-3,322
-48% -$55.4K ﹤0.01% 5198
2021
Q1
$120K Sell
6,983
-1,964
-22% -$33.8K ﹤0.01% 4844
2020
Q4
$140K Buy
8,947
+5,897
+193% +$92.3K ﹤0.01% 4497
2020
Q3
$58K Sell
3,050
-4,401
-59% -$83.7K ﹤0.01% 4697
2020
Q2
$102K Sell
7,451
-688
-8% -$9.42K ﹤0.01% 4470
2020
Q1
$86K Sell
8,139
-11,554
-59% -$122K ﹤0.01% 4553
2019
Q4
$368K Buy
19,693
+14,594
+286% +$273K ﹤0.01% 4143
2019
Q3
$53K Buy
+5,099
New +$53K ﹤0.01% 5229
2019
Q1
Sell
-10,493
Closed -$53K 7150
2018
Q4
$53K Buy
+10,493
New +$53K ﹤0.01% 5148
2018
Q2
Sell
-191
Closed -$1K 7183
2018
Q1
$1K Buy
+191
New +$1K ﹤0.01% 6770
2017
Q4
Sell
-229
Closed -$1K 6999
2017
Q3
$1K Buy
+229
New +$1K ﹤0.01% 6671
2016
Q3
Sell
-29,779
Closed -$623K 6868
2016
Q2
$623K Buy
+29,779
New +$623K ﹤0.01% 3019
2016
Q1
Sell
-2,291
Closed -$25K 6889
2015
Q4
$25K Buy
+2,291
New +$25K ﹤0.01% 5368
2015
Q3
Sell
-465
Closed -$8K 6963
2015
Q2
$8K Buy
+465
New +$8K ﹤0.01% 6095